Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) main shareholder Hengqin Dingdian and its concerted action party have completed the reduction of 757,400 shares.
West Point Pharmaceutical Co., Ltd. (301130.SZ) announced that its shareholder, Hengqin Dingdian Equity Investment Fund Partnership, holds more than 5% of the company's shares.
Announcement of Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): Shareholders holding more than 5% of the company, Hengqin Dingdian Equity Investment Fund Partnership Enterprise (Limited Partnership) (referred to as "Hengqin Dingdian") and its concerted action person Zhuhai Hengqin Runhuiyi Investment Partnership Enterprise (Limited Partnership) (formerly known as Hengqin Runhuiyi Equity Investment Fund Partnership Enterprise (Limited Partnership)) (referred to as "Zhuhai Hengqin Runhuiyi"), have collectively reduced their shares by 757,400 shares, accounting for 0.99% of the total share capital. The implementation of this reduction plan has been completed.
Related Articles
US Stock Market Move | Same-store sales growth in the first fiscal quarter fell short of expectations, and Caseys General Stores (CASY.US) plummeted over 15%.
A-shares Evening Highlights | Risk Alert Sounded! Oil prices once again stand above $100, "triple kill" in stocks, bonds, and currencies approaches.
US Stock Market Move | Alphabet Inc. Class CA (GOOGL.US) fell nearly 3%, hitting a new low since July 27.
US Stock Market Move | Same-store sales growth in the first fiscal quarter fell short of expectations, and Caseys General Stores (CASY.US) plummeted over 15%.
A-shares Evening Highlights | Risk Alert Sounded! Oil prices once again stand above $100, "triple kill" in stocks, bonds, and currencies approaches.
US Stock Market Move | Alphabet Inc. Class CA (GOOGL.US) fell nearly 3%, hitting a new low since July 27.
RECOMMEND
